Cargando…

Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCCmec type IV methicillin-resistant Staphylococcus aureus (MRSA)

Background. Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogenic bacteria involved in a wide spectrum of human diseases. Many virulence factors promote this widespread propagation. One important factor is acquiring antibiotic resistance genes, which leads to a reduction in the availabi...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlSaleh, Abdullah, Shahid, Mohammed, Farid, Eman, Kamal, Nermin, Bindayna, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996180/ https://www.ncbi.nlm.nih.gov/pubmed/36910508 http://dx.doi.org/10.1099/acmi.0.000475.v4

Ejemplares similares

The Effect of Ascorbic Acid and Nicotinamide on Panton–Valentine Leukocidin Cytotoxicity: An Ex Vivo Study
por: AlSaleh, Abdullah, et al.
Publicado: (2023)

Reduction of Panton-Valentine Leukocidin Production in the Staphylococcal Strain USA300 After In Vitro Ascorbic Acid and Nicotinamide Treatment
por: AlSaleh, Abdullah, et al.
Publicado: (2023)

Role of SCCmec type in resistance to the synergistic activity of oxacillin and cefoxitin in MRSA
por: Reichmann, Nathalie T., et al.
Publicado: (2017)

Difference in agr Dysfunction and Reduced Vancomycin Susceptibility between MRSA Bacteremia Involving SCCmec Types IV/IVa and I–III
por: Jang, Hee-Chang, et al.
Publicado: (2012)

Pacemaker-associated infection caused by ST81/SCCmec IV methicillin-resistant, vancomycin-intermediate Staphylococcus aureus in Japan
por: Sakurada, M., et al.
Publicado: (2020)

Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predominance of SCCmec types IV, V and VI
por: Conceição, T., et al.
Publicado: (2010)

Multidrug-Resistant Staphylococcus aureus Isolates in a Tertiary Care Hospital, Kingdom of Bahrain
por: AlSaleh, Abdullah, et al.
Publicado: (2023)

Increased Incidence and Plasma-Biofilm Formation Ability of SCCmec Type IV Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated From Patients With Bacteremia
por: Hamada, Masakaze, et al.
Publicado: (2021)

Impact of agr dysfunction on virulence profiles and infections associated with a novel methicillin-resistant Staphylococcus aureus (MRSA) variant of the lineage ST1-SCCmec IV
por: Ferreira, Fabienne Antunes, et al.
Publicado: (2013)

Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Müller, Patrick, et al.
Publicado: (2013)

The First Report of a Methicillin-Resistant Staphylococcus aureus Isolate Harboring Type IV SCCmec in Thailand
por: Santimaleeworagun, Wichai, et al.
Publicado: (2021)

Clinical and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in New Zealand: Rapid Emergence of Sequence Type 5 (ST5)-SCCmec-IV as the Dominant Community-Associated MRSA Clone
por: Williamson, Deborah A., et al.
Publicado: (2013)

Community-acquired methicillin-resistant Staphylococcus aureus from ST1 lineage harboring a new SCCmec IV subtype (SCCmec IVm) containing the tetK gene
por: Côrtes, Marina F, et al.
Publicado: (2018)

The dissemination of ST80-SCCmec-IV community-associated methicillin resistant Staphylococcus aureus clone in Kuwait hospitals
por: Udo, Edet E, et al.
Publicado: (2010)

High frequency of SCCmec type IV and multidrug-resistant SCCmec type I among hospital acquired methicillin-resistant Staphylococcus aureus isolates in Birjand Imam Reza Hospital, Iran
por: Sadeghi Moghaddam, Toktam, et al.
Publicado: (2022)

Complete Genome Sequence of Staphylococcus aureus XN108, an ST239-MRSA-SCCmec III Strain with Intermediate Vancomycin Resistance Isolated in Mainland China
por: Zhang, Xia, et al.
Publicado: (2014)

Community-Acquired Necrotizing Pneumonia Caused by ST72-SCCmec Type IV-Methicillin-Resistant Staphylococcus aureus in Korea
por: Hwang, Ji-Won, et al.
Publicado: (2013)

Investigation of SCCmec types I–IV in clinical isolates of methicillin-resistant coagulase-negative staphylococci in Ahvaz, Southwest Iran
por: Abbasi Montazeri, Effat, et al.
Publicado: (2020)

SCCmec Typing in Methicillin-Resistant Staphylococcus aureus Strains of Animal Origin
por: Jansen, Marc D., et al.
Publicado: (2009)

CC8 MRSA Strains Harboring SCCmec Type IVc are Predominant in Colombian Hospitals
por: Jiménez, J. Natalia, et al.
Publicado: (2012)

Multiresistant ST59-SCCmec IV-t437 clone with strong biofilm-forming capacity was identified predominantly in MRSA isolated from Chinese children
por: Yang, Xin, et al.
Publicado: (2017)

A Rare Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Enterocolitis Treated With Oral Vancomycin
por: Tagliaferri, Ariana R, et al.
Publicado: (2021)

Vancomycin resistance among MRSA
por: Kumar, V. Anil
Publicado: (2012)

Composite SCCmec Element in Single-locus Variant (ST217) of Epidemic MRSA-15 Clone
por: Vignaroli, Carla, et al.
Publicado: (2014)

Diversity of SCCmec Elements in Methicillin-Resistant Coagulase-Negative Staphylococci Clinical Isolates
por: Zong, Zhiyong, et al.
Publicado: (2011)

Methicillin-Resistant Macrococcus bohemicus Encoding a Divergent SCCmecB Element
por: Foster, Geoffrey, et al.
Publicado: (2020)

Genetic diversity of Staphylococcus aureus strains from a teaching hospital in Isfahan, Iran: The emergence of MRSA ST639- SCCmec III and ST343- SCCmec III
por: Sedaghat, Hossein, et al.
Publicado: (2018)

Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
por: Pletz, Mathias W, et al.
Publicado: (2010)

Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Trinh, Trang D, et al.
Publicado: (2017)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

Effects of topical Vancomycin Dressing on Methicillin-Resistant Staphylococcus Aureus (MRSA) positive diabetic foot ulcers
por: Saif, Anas Bin, et al.
Publicado: (2019)

Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)
por: Thitiananpakorn, Kanate, et al.
Publicado: (2020)

2003. Vancomycin Discontinuation Is Supported by-negative Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) in Patients with Pneumonia
por: Pleasants, Katherine A, et al.
Publicado: (2019)

Predominant Dissemination of PVL-Negative CC89 MRSA with SCCmec Type II in Children with Impetigo in Japan
por: Kikuta, H., et al.
Publicado: (2011)

ST9 MRSA strains carrying a variant of type IX SCCmec identified in the Thai community
por: Lulitanond, Aroonlug, et al.
Publicado: (2013)

SCCmec typing of PVL-positive community-acquired Staphylococcus aureus (CA-MRSA) at a Japanese hospital
por: Funaki, Toshitaka, et al.
Publicado: (2019)

High frequency of increased triclosan MIC among CC5 MRSA and risk of misclassification of the SCCmec into types
por: Viana, Alice Slotfeldt, et al.
Publicado: (2022)

Natural transformation allows transfer of SCCmec-mediated methicillin resistance in Staphylococcus aureus biofilms
por: Maree, Mais, et al.
Publicado: (2022)

Evaluation of the Combined Effects of Stilbenoid from Shorea gibbosa and Vancomycin against Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Basri, Dayang Fredalina, et al.
Publicado: (2012)

78. Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Screen on Vancomycin Utilization for Respiratory Tract Infections
por: Debnath, Ashita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9t3hikr373q4iifhrt2p1oiqev